These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 31173781)

  • 1. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
    Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
    Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice.
    Xiao L; Dou W; Wang Y; Deng H; Xu H; Pan Y
    Biochem Pharmacol; 2023 Oct; 216():115752. PubMed ID: 37634598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-
    Guo S; Chen S; Ma J; Ma Y; Zhu J; Ma Y; Liu Y; Wang P; Pan Y
    Mediators Inflamm; 2019; 2019():5796491. PubMed ID: 31354386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of Escherichia coli Nissle 1917 on the intestinal barrier is mediated by inhibition of RhoA/ROCK2/MLC signaling via TLR-4.
    Xu H; Hou Q; Zhu J; Feng M; Wang P; Pan Y
    Life Sci; 2022 Mar; 292():120330. PubMed ID: 35051420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
    Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
    J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
    Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli K12: An evolving opportunistic commensal gut microbe distorts barrier integrity in human intestinal cells.
    Bhat MI; Sowmya K; Kapila S; Kapila R
    Microb Pathog; 2019 Aug; 133():103545. PubMed ID: 31112772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer.
    Jiang Y; Fan L
    J Ethnopharmacol; 2021 Feb; 266():113456. PubMed ID: 33039631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
    Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
    J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced Diarrhea.
    Wardill HR; Bowen JM; Van Sebille YZ; Secombe KR; Coller JK; Ball IA; Logan RM; Gibson RJ
    Mol Cancer Ther; 2016 Nov; 15(11):2767-2779. PubMed ID: 27550942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer Membrane Vesicles and Soluble Factors Released by Probiotic
    Alvarez CS; Badia J; Bosch M; Giménez R; Baldomà L
    Front Microbiol; 2016; 7():1981. PubMed ID: 28018313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretions of Bifidobacterium infantis and Lactobacillus acidophilus Protect Intestinal Epithelial Barrier Function.
    Guo S; Gillingham T; Guo Y; Meng D; Zhu W; Walker WA; Ganguli K
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):404-412. PubMed ID: 28230606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on Intestinal Epithelial Cells and a Rat Model of 5-Fluorouracil-Induced Mucositis.
    Wang H; Jatmiko YD; Bastian SE; Mashtoub S; Howarth GS
    Nutr Cancer; 2017; 69(2):307-318. PubMed ID: 28094590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
    Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
    PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells.
    Noda S; Tanabe S; Suzuki T
    Mol Nutr Food Res; 2013 Nov; 57(11):2019-28. PubMed ID: 23868418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
    Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a combination of in vitro models to investigate the impact of chlorpyrifos and inulin on the intestinal microbiota and the permeability of the intestinal mucosa.
    Réquilé M; Gonzàlez Alvarez DO; Delanaud S; Rhazi L; Bach V; Depeint F; Khorsi-Cauet H
    Environ Sci Pollut Res Int; 2018 Aug; 25(23):22529-22540. PubMed ID: 29808406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.